Opicapone in German Parkinson's disease patients with motor fluctuations: Results on WOQ-9, QoL and non-motor symptoms.

被引:0
作者
Reichmann, H. [1 ]
Eggert, K. [2 ]
Oehlwein, C.
Warnecke, T. [3 ]
Lees, A. [4 ]
Kemmer, M. [5 ]
Soares-da-Silva, P. [6 ,7 ]
机构
[1] Univ Dresden, Dept Neurol, Dresden, Germany
[2] Philipps Univ Marburg, Dept Neurol, Marburg, Germany
[3] WWU Munster, Klinikum Osnabruck, Acad Teaching Hosp, Dept Neurol & Neurorehabil, Osnabruck, Germany
[4] UCL, Reta Lila Weston Inst, London, England
[5] BIAL Deutschland MorfeldenWalldorf, Morfelden Walldorf, Germany
[6] BIAL Portela & Ca SA, Coronado S Romao & S Mamede, Trofa, Portugal
[7] Univ Porto, MedInUP, Ctr Drug Discovery & Innovat Med, BIAL Portela & Ca SA, Porto, Portugal
关键词
LEVODOPA; ADJUNCT;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPO-612
引用
收藏
页码:768 / 768
页数:1
相关论文
共 3 条
  • [1] Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial
    Ferreira, Joaquim J.
    Lees, Andrew
    Rocha, Jose-Francisco
    Poewe, Werner
    Rascol, Olivier
    Soares-da-Silva, Patricio
    [J]. LANCET NEUROLOGY, 2016, 15 (02) : 154 - 165
  • [2] Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations A Randomized Clinical Trial
    Lees, Andrew J.
    Ferreira, Joaquim
    Rascol, Olivier
    Poewe, Werner
    Rocha, Jose-Francisco
    McCrory, Michelle
    Soares-da-Silva, Patricio
    [J]. JAMA NEUROLOGY, 2017, 74 (02) : 197 - 206
  • [3] Reichmann H, 2020, TRANSL NEURODEGENER, V9, DOI 10.1186/s40035-020-00187-1